Liz Essley Whyte will be joining The Wall Street Journal to cover the intersection of pharmaceuticals and Washington, including the U.S. Food and Drug Admission, Congress, the White House and how drug makers and federal policy makers interact.
Recently, Whyte was working as a senior investigative reporter at The Center for Public Integrity. She had been with the nonprofit newsroom for over 7 years, previously covering health, money and influence in politics.
Before that, she reported on money in state politics using television and campaign finance data as an American University fellow. She also served as managing editor of The Philanthropy Magazine, a quarterly magazine.
She has also written for The Washington Examiner.
Whyte has a B.A. from Hillsdale College and a master’s degree from American University.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…